KATHRYN E FALBERG Insider Trading $AXON Sio Gene Therapies Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KATHRYN E FALBERG.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KATHRYN E FALBERG. KATHRYN E FALBERG is Director in HUMAN GENOME SCIENCES INC ($HGSI) and Director in MEDIVATION, INC. ($MDVN) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Director in aTYR PHARMA INC ($LIFE) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and Director in Aimmune Therapeutics, Inc. ($AIMT) and Director in Axovant Sciences Ltd. ($AXON) and Director in Trade Desk, Inc. ($TTD) and Director in UroGen Pharma Ltd. ($URGN) and Director in Arcus Biosciences, Inc. ($RCUS) and Director in Nuvation Bio Inc. ($PANA).

KATHRYN E FALBERG in Sio Gene Therapies Inc.

Trading Symbol: AXON
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 53,937 shares
Current Value: $699,563
Latest Transaction: May 16 2017
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of KATHRYN E FALBERG in Sio Gene Therapies Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AIMT, RCUS, LIFE, BMRN, GYHT, HGSI, MDVN, NUVB, AXON, TTD, TCDA, URGN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 16 2017	AXON	Axovant Sciences L ...	FALBERG KATHRYN E	Director	Option Exercise	A	21.90	70,000	1,533,000	70,000
Apr 19 2017	AXON	Axovant Sciences L ...	FALBERG KATHRYN E	Director	Buy	P	18.54	53,937	999,992	53,937	0 to 53.9 K

Page: 1